IMVT
Price
$17.41
Change
-$0.52 (-2.90%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
3.03B
15 days until earnings call
Intraday Buy/Sell Signals
ROIV
Price
$17.11
Change
+$0.12 (+0.71%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
11.68B
31 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

IMVT vs ROIV

Header iconIMVT vs ROIV Comparison
Open Charts IMVT vs ROIVBanner chart's image
Immunovant
Price$17.41
Change-$0.52 (-2.90%)
Volume$40.13K
Capitalization3.03B
Roivant Sciences
Price$17.11
Change+$0.12 (+0.71%)
Volume$128.73K
Capitalization11.68B
IMVT vs ROIV Comparison Chart in %
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMVT vs. ROIV commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Hold and ROIV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (IMVT: $17.93 vs. ROIV: $17.11)
Brand notoriety: IMVT and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 103% vs. ROIV: 97%
Market capitalization -- IMVT: $3.03B vs. ROIV: $11.68B
IMVT [@Biotechnology] is valued at $3.03B. ROIV’s [@Biotechnology] market capitalization is $11.68B. The market cap for tickers in the [@Biotechnology] industry ranges from $104.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than IMVT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 6 TA indicator(s) are bullish while ROIV’s TA Score has 2 bullish TA indicator(s).

  • IMVT’s TA Score: 6 bullish, 3 bearish.
  • ROIV’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, IMVT is a better buy in the short-term than ROIV.

Price Growth

IMVT (@Biotechnology) experienced а +11.54% price change this week, while ROIV (@Biotechnology) price change was +6.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.40%. For the same industry, the average monthly price growth was +16.16%, and the average quarterly price growth was +80.98%.

Reported Earning Dates

IMVT is expected to report earnings on Oct 31, 2025.

ROIV is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (-1.40% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($11.7B) has a higher market cap than IMVT($3.04B). ROIV YTD gains are higher at: 44.632 vs. IMVT (-29.713). IMVT has higher annual earnings (EBITDA): -470.69M vs. ROIV (-1.18B). ROIV has more cash in the bank: 4.5B vs. IMVT (599M). IMVT has less debt than ROIV: IMVT (98K) vs ROIV (99.7M). ROIV has higher revenues than IMVT: ROIV (23.2M) vs IMVT (0).
IMVTROIVIMVT / ROIV
Capitalization3.04B11.7B26%
EBITDA-470.69M-1.18B40%
Gain YTD-29.71344.632-67%
P/E RatioN/A1.97-
Revenue023.2M-
Total Cash599M4.5B13%
Total Debt98K99.7M0%
FUNDAMENTALS RATINGS
IMVT: Fundamental Ratings
IMVT
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMVTROIV
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
71%
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 9 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DFEV32.380.29
+0.90%
Dimensional Emerging Markets Value ETF
MYCJ25.170.06
+0.24%
SPDR SSGA My2030 Corporate Bond ETF
SZOXF7.01N/A
N/A
Deutsche Bank AG (London Branch)
FLV72.94-0.69
-0.93%
American Century Foc Lrg Cp Val ETF
PYZ111.61-1.96
-1.73%
Invesco DW Basic Materials Momt ETF

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with IDYA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
-2.90%
IDYA - IMVT
53%
Loosely correlated
-2.43%
ROIV - IMVT
52%
Loosely correlated
+0.71%
CLDX - IMVT
49%
Loosely correlated
-2.89%
NUVL - IMVT
49%
Loosely correlated
+0.87%
DNLI - IMVT
49%
Loosely correlated
+2.51%
More